Westchester Capital Management (New York)’s PRA Health Sciences, Inc. PRAH Stock Holding History

Westchester Capital Management (New York)’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-733,331	Closed	-$121M	–	438
2021 Q2	$121M	Buy	733,331 +294,128	+67%	+$49.1M	2.81%	13
2021 Q1	$67.3M	Buy	+439,203	New	+$59.6M	1.86%	16

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Westchester Capital Management (New York)'s PRAH Position: Q3 2021 in Review

Westchester Capital Management (New York) sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 733,331 shares — an estimated $121M sold.

Westchester Capital Management (New York) first reported a position in PRAH in Q1 2021 and held it in 2 quarters. The position peaked at $121M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Westchester Capital Management (New York) reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Westchester Capital Management (New York) sold 733,331 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $121M.
Westchester Capital Management (New York) first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 2 quarters.
Westchester Capital Management (New York)'s PRA Health Sciences, Inc. position peaked at $121M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.